Literature DB >> 26735861

Progress and perspective of inorganic nanoparticle-based siRNA delivery systems.

Ying Jiang1, Shuaidong Huo1,2, Joseph Hardie1, Xing-Jie Liang2, Vincent M Rotello1.   

Abstract

INTRODUCTION: Small interfering RNA (siRNA) is an effective method for regulating the expression of proteins, even "undruggable" ones that are nearly impossible to target through traditional small molecule therapeutics. Delivery to the cell and then to the cytosol is the primary requirement for realization of therapeutic potential of siRNA. AREAS COVERED: We summarize recent advances in the design of inorganic nanoparticle with surface functionality and physicochemical properties engineered for siRNA delivery. Specifically, we discuss the main approaches developed so far to load siRNA into/onto NPs, and NP surface chemistry engineered for enhanced intracellular siRNA delivery, endosomal escape, and targeted delivery of siRNA to disease cells and tissues. EXPERT OPINION: Several challenges remain in developing inorganic NPs for efficient and effective siRNA delivery. Getting the material to the chosen site is important, however the greatest hurdle may well be delivery into the cytosol, either through efficient endosomal escape or by direct cytosolic siRNA delivery. Effective delivery at the organismic and cellular level coupled with biocompatible vehicles with low immunogenic response will facilitate the clinical translation of RNAi for the treatment of genetic diseases.

Entities:  

Keywords:  Cancer therapy; RNAi; inorganic nanoparticle; siRNA delivery; surface chemistry

Mesh:

Substances:

Year:  2016        PMID: 26735861      PMCID: PMC4914043          DOI: 10.1517/17425247.2016.1134486

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  73 in total

1.  Retroviral delivery of small interfering RNA into primary cells.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  First evidence of RNA interference mechanism induced in human: getting closer to a cure?

Authors:  Lise Roth
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

Review 3.  Functionalized gold nanoparticles for drug delivery.

Authors:  Gang Han; Partha Ghosh; Vincent M Rotello
Journal:  Nanomedicine (Lond)       Date:  2007-02       Impact factor: 5.307

4.  Use of adeno-associated viral vector for delivery of small interfering RNA.

Authors:  Raghuvir S Tomar; Hittu Matta; Preet M Chaudhary
Journal:  Oncogene       Date:  2003-08-28       Impact factor: 9.867

Review 5.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

6.  Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules.

Authors:  Ying Jiang; Rui Tang; Bradley Duncan; Ziwen Jiang; Bo Yan; Rubul Mout; Vincent M Rotello
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-12       Impact factor: 15.336

7.  N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery.

Authors:  Gang Liu; Jin Xie; Fan Zhang; Zhiyong Wang; Kui Luo; Lei Zhu; Qimeng Quan; Gang Niu; Seulki Lee; Hua Ai; Xiaoyuan Chen
Journal:  Small       Date:  2011-08-22       Impact factor: 13.281

8.  Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.

Authors:  Yuhan Lee; Soo Hyeon Lee; Jee Seon Kim; Atsushi Maruyama; Xuesi Chen; Tae Gwan Park
Journal:  J Control Release       Date:  2010-09-30       Impact factor: 9.776

9.  Image-guided breast tumor therapy using a small interfering RNA nanodrug.

Authors:  Mohanraja Kumar; Mehmet Yigit; Guangping Dai; Anna Moore; Zdravka Medarova
Journal:  Cancer Res       Date:  2010-08-11       Impact factor: 12.701

10.  Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.

Authors:  Alexander H van Asbeck; Andrea Beyerle; Hesta McNeill; Petra H M Bovee-Geurts; Staffan Lindberg; Wouter P R Verdurmen; Mattias Hällbrink; Ulo Langel; Olaf Heidenreich; Roland Brock
Journal:  ACS Nano       Date:  2013-04-30       Impact factor: 15.881

View more
  17 in total

1.  Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment.

Authors:  Ying Jiang; Joseph Hardie; Yuanchang Liu; Moumita Ray; Xiang Luo; Riddha Das; Ryan F Landis; Michelle E Farkas; Vincent M Rotello
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

2.  siRNA intervention inhibiting viral replication and delivery strategies for treating herpes simplex viral infection.

Authors:  Vyshnavi Manda; Venkata Rao Josyula; Raghu Chandrashekar Hariharapura
Journal:  Virusdisease       Date:  2019-01-22

3.  Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.

Authors:  Anish Babu; Anupama Munshi; Rajagopal Ramesh
Journal:  Drug Dev Ind Pharm       Date:  2017-05-19       Impact factor: 3.225

Review 4.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

Review 5.  Mechanisms of immune response to inorganic nanoparticles and their degradation products.

Authors:  Raziye Mohammapdour; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2021-11-02       Impact factor: 15.470

6.  Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.

Authors:  Jacob S Brenner; Samir Mitragotri; Vladimir R Muzykantov
Journal:  Annu Rev Biomed Eng       Date:  2021-03-31       Impact factor: 11.324

Review 7.  Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.

Authors:  Ghanbar Mahmoodi Chalbatani; Hassan Dana; Elahe Gharagouzloo; Santiago Grijalvo; Ramon Eritja; Craig D Logsdon; Fereidoon Memari; Seyed Rouhollah Miri; Mahdi Rezvani Rad; Vahid Marmari
Journal:  Int J Nanomedicine       Date:  2019-05-02

8.  Gold-DNA nanosunflowers for efficient gene silencing with controllable transformation.

Authors:  Shuaidong Huo; Ningqiang Gong; Ying Jiang; Fei Chen; Hongbo Guo; Yaling Gan; Zhisen Wang; Andreas Herrmann; Xing-Jie Liang
Journal:  Sci Adv       Date:  2019-10-02       Impact factor: 14.136

9.  Gene Silencing via PDA/ERK2-siRNA-Mediated Electrospun Fibers for Peritendinous Antiadhesion.

Authors:  Shen Liu; Fei Wu; Shanshan Gu; Tianyi Wu; Shun Chen; Shuai Chen; Chongyang Wang; Guanlan Huang; Tuo Jin; Wenguo Cui; Bruno Sarmento; Lianfu Deng; Cunyi Fan
Journal:  Adv Sci (Weinh)       Date:  2018-11-20       Impact factor: 16.806

Review 10.  Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.

Authors:  Rasha Itani; Mansour Tobaiqy; Achraf Al Faraj
Journal:  Theranostics       Date:  2020-05-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.